A subset of AR-positive, triple-negative breast carcinomas, which lack ER and progestrone receptor (PR) expression and ErbB2 overexpression, appear to be dependent on AR signalling for growth50, 51. Here, ERBB2 is linked to triple-negative breast carcinoma.